Application of simultaneously destroying HBB competition and HBG apparent silencing in treatment of beta-hemoglobin disease
The invention discloses an application of simultaneously destroying HBB competition and HBG apparent silencing in treatment of beta-hemoglobin disease, and finds for the first time that expression conversion of gamma-globin to beta-globin can be completely reversed by destroying interaction between...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses an application of simultaneously destroying HBB competition and HBG apparent silencing in treatment of beta-hemoglobin disease, and finds for the first time that expression conversion of gamma-globin to beta-globin can be completely reversed by destroying interaction between HBB and LCR and simultaneously relieving apparent silencing on HBG. The discovery has an important clinical application prospect in the field of beta-hemoglobin disease gene therapy.
本发明公开了同时破坏HBB竞争和HBG表观沉默在治疗β-血红蛋白病中的应用,本发明首次发现破坏HBB与LCR间的相互作用的同时解除HBG上的表观沉默可以完全逆转γ-向β-珠蛋白表达转换,该发现在β-血红蛋白病基因治疗领域具有重要的临床应用前景。 |
---|